Since increased HIF-1α levels stimulate enzymes responsible for cancer survival [52], it is interesting to note that despite higher vessel density and a higher percentage of HIF-1α+ cells, high-dose PSP-2 treated tumors experienced a similar weight reduction as low-dose PSP-2 specimens when compared to control (SI Figure S2). The gene discussed is HIF1A; the disease is cancer.